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T hermal ablation is a minimally invasive tumor treatment method whose results are comparable 
to surgical treatment [1-5].  In contrast,  percutaneous 
ablation treatments run a risk of hemorrhage and tumor 
seeding after needle extraction [6-13].  The incidences 
of hemorrhage and tumor seeding by percutaneous 
ablation have been reported to be 1.5-8.1% [6 , 7] and 
0.2-0.5% [11 , 12],  respectively.  Radiofrequency abla-
tion (RFA) is less likely to lead to a hemorrhagic com-
plication than is cryoablation (CA) [8 , 14],  although 
the use of a thinner probe could improve the outcome of 
cryoablation [15].  Needle tract ablation using RFA sys-
tems may be a possible method to prevent these events;  
however,  this procedure cannot be performed using a 
cryoprobe [9 , 16].
We developed an experimental device for perform-
ing needle tract ablation using a cryoprobe.  The pur-
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To assess the feasibility of needle tract ablation in liver tissue in ex vivo and in vivo animal models using a cryo-
probe and electrosurgical device.  The experimental device is made by inserting a cryoprobe through an intro-
ducer sheath for insulation,  with 2-cm of probe tip projecting out.  A beagle liver was punctured by the device,  
and electric current was applied at 30-W with the electrosurgical knife touching the non-insulated device base.  
The discolored area of cut surface along the device was evaluated in 5 application-time groups (5 , 10 , 15 , 20,  or 
25 seconds).  An ex vivo experiment was performed to determine an ablation algorithm with an appropriate 
application time by comparison with radiofrequency ablation (RFA) results.  Thereafter,  an in vivo experiment 
was performed to verify the algorithm’s feasibility.  In the ex vivo model,  the cut surface demonstrated different 
amounts of discolored area according to the application time.  The total discolored area in the 20-seconds group 
was similar to that by RFA.  In the in vivo model,  the liver did not bleed,  the total discolored area was similar to 
that ex vivo,  and coagulation necrosis was confirmed by photomicrograph.  Needle tract ablation can be per-
formed using the experimental device and electrosurgical device.
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pose of this study was to assess the feasibility of needle 
tract ablation in the liver tissue in ex vivo and in vivo 
animal models using a cryoprobe combined with an 
electrosurgical device.
Materials and Methods
In this study,  an ex vivo experiment was performed 
to determine an appropriate ablation algorithm.  
Thereafter,  an in vivo experiment was performed to 
verify the feasibility of tract ablation with the algorithm.
Devices
a.  RFA system
A 17-gauge internally cooled needle electrode and a 
generator (Cool-tip RFA system; Covidien,  Mansfield,  
MA,  USA) were used as the reference system for needle 
tract ablation.  The generator could produce a radiofre-
quency electric current of 472 kHz.  The needle we used 
had a non-insulated tip length of 2 cm; other parts of 
the needle were fully insulated.
b.  Experimental CA device
A 17-gauge cryoprobe (Ice-Rod,  Galil Medical,  
Yokneam,  Israel) was insulated by inserting it through 
a 4-French and 10-cm length introducer sheath 
(Radifocus Introducer II H,  Terumo,  Tokyo),  with 
2 cm of the probe tip projecting out (Fig. 1A).
c.  Electrosurgical devices
In the ex vivo model,  a Conmed System 5000 elec-
trosurgical generator (CONMED,  Utica,  NY,  USA) 
was used for electrical energy deposition.  The generator 
could produce radiofrequency current at 562 kHz.  On 
the other hand,  the ICC 50 generator (Erbe 
Elektromedizin GmbH,  Germany) used in the in vivo 
model could produce electric current at 510-550 kHz.  
A monopolar handpiece electrosurgical knife was used 
in both the ex vivo and in vivo models.
Ex vivo model
a.  Procedure
The laboratory room temperature was maintained at 
20°C.  Around 100 ml of saline was poured into a stain-
less-steel tray and a beaker,  respectively.  For the exper-
imental CA device system and RFA system,  the return 
electrodes were affixed to the bottom of the tray,  and 
the cable was connected to the generator.  Further,  an 
electrosurgical knife or an RFA needle electrode was 
connected to each correspondent generator.  A beagle 
liver was then placed in the tray (Fig. 1B).
The liver was punctured by the RFA needle electrode 
(depth of puncture > 2 cm).  After the needle tip place-
ment,  electric current was applied at 30 W,  without 
10 Gobara et al. Acta Med.  Okayama　Vol.  75,  No.  1
Ａ Ｂ
Ｃ
Fig. 1　 (A) The experimental cryoablation device: a cryoprobe with a project-
ing probe tip of 2 cm inserted through an introducer sheath.  (B) A beagle liver 
in saline on a stainless-steel tray,  with the return electrodes of the radiofre-
quency ablation system (arrow) and electrosurgical system (arrowhead) affixed 
to the bottom of the tray.  (C) The tip of the electrosurgical knife touching the 
non-insulated base of the cryoprobe to conduct electric current.
iced water circulation,  until it was automatically shut 
off when the impedance rapidly increased.  This proce-
dure was repeated 5 times after repositioning the needle 
electrode.  The experimental CA device was then placed 
in the same way,  and an electric current was applied at 
30 W with the electrosurgical knife touching the non- 
insulated base of the device (Fig. 1C).  The application 
times were 5 , 10 , 15 , 20,  and 25 sec; this procedure was 
also repeated 5 times,  after repositioning the device tip 
each time.  Before each penetration,  the RF needle and 
experimental CA device were dunked in the saline in 
the beaker to cool the probe tip down to room tempera-
ture.  After each application,  the liver was sectioned 
along the probe tip.
b.  Data collection
We observed a discolored area (ablation zone) on the 
cut surface in each section and recorded the maximum 
and minimum width perpendicular to the needle (mm).  
We also recorded the appearance of the liver during 




The test subject was a female beagle (12.0 kg).  The 
study was approved by the institutional animal ethics 
committee of Osaka City University (no. 17001: 7/12/ 
2017),  where the in vivo animal experiment was per-
formed.
b.  Procedure
All experiments were performed by (A.K. and T.K.) 
in compliance with the regulations for animal experi-
ments.  The beagle was anesthetized with an intramus-
cular injection of 150 mg of ketamine and 10 mg of 
midazolam.  Anesthesia was maintained intravenously 
with 25 mg/kg of pentobarbital sodium.  The animal 
could breathe spontaneously throughout the procedure.
This procedure involved exposing the liver surface 
through laparotomy.  The return electrode was affixed to 
the lower abdominal wall of the beagle.  Under direct 
visual guidance,  the device tip punctured the liver 
(depth > 2 cm).  The electric current was then applied at 
30 W for 20 sec; this duration was chosen based on the 
results obtained from the ex vivo model.  After five appli-
cations,  each followed by a repositioning of the device 
tip,  the liver was harvested and sectioned along the 
probe tip.  A photograph of each cut surface was taken,  
and specimens from each cut surface were prepared for 
histologic evaluation.
c.  Data collection
The liver was observed for the presence of bleeding 
from the insertion site after each withdrawal of the 
device.  After the final withdrawal,  the discolored area 
on the cut surface was measured,  and the extent of 
coagulation necrosis was evaluated on the photomicro-
graph afterward.
Statistical analyses. In the in vivo model,  the 
maximum width perpendicular to the device of each 
application-time group was compared to that of the 
RFA needle group using an unpaired Student’s t-test.  A 
P-value of < 0.05 was considered to indicate a statisti-
cally significant difference.  Statistical Package for the 
Social Science version 22.0 software (IBM Corp.,  
Armonk,  NY,  USA) was used for the statistical analy-
ses.
Results
Ex vivo model. The beagle liver was easily punc-
tured,  although the experimental CA device had caliber 
difference between the needle tip and introducer sheath.  
The electric current was successfully passed through 
both needles.  The cut surface along the RFA needle 
electrode demonstrated a circumferential discolored 
area around the non-insulated tip.  On the other hand,  
the cut surface along the experimental CA device 
demonstrated the discolored area only around both ends 
of the projecting probe tip in the 5-sec and 10-sec 
groups (Fig. 2A,  arrowhead) and circumferentially 
around the tip in the ≥ 15-sec groups (Fig. 2B).  In the 
25-sec group,  vaporing was seen around the insertion 
site during application; additionally,  the tip of the 
introducer sheath was charred upon withdrawal of the 
device.  The maximum and minimum widths perpen-
dicular to the device are summarized in Table 1.  The 
maximum widths in the 15- and 20-sec groups were not 
significantly different when compared with those in the 
RFA group.
In vivo model. Electric current was successfully 
passed through the beagle liver in the in vivo animal 
model.  After each application followed by the with-
drawal of the cryoprobe,  the liver did not bleed from 
the puncture site.  The cut surface of the needle tract 
demonstrated a discolored area around the device tip 
(Fig. 3A).  The maximum widths perpendicular to the 
device were 5.6 ± 0.6 mm.  The photomicrograph of the 
cut surface showed coagulation necrosis correspondent 
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to about two-thirds of the discolored area (Fig. 3B).
Discussion
This experimental device,  including the cryoprobe,  
introducer sheath,  and electrosurgical device,  was eas-
ily made with commercially available products.  We 
used the introducer sheath as an insulating device for 
the following reasons.  First,  an introducer sheath is 
typically made of resinous material and provides good 
insulation.  Second,  the inner diameter of the 4-Fr 
introducer sheath is about 4.4- or 4.5-Fr (≈ 17-gauge),  
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Fig. 2　 Ex vivo model: Photographs of the cut surface along the needle: at 10sec of cryoablation (A); at 20sec of cryoablation (B).
Ａ Ｂ
Fig. 3　 In vivo model: The cut surface of the liver along the needle shows a discolored area (arrowhead) (A),  and a photomicrograph of 
the cut surface demonstrates a discolored area (arrow) and coagulation necrosis (arrowhead) along the needle (B).
Table 1　 Width of the discolored area with each needle type and application time
Needle type
Application time of 
electric current 
(sec)







RFA needle ＊ 6.4±0.9 4.8±0.8 †
5 2.2±0.4 0 <0.001
10 4.4±0.9 0 <0.001
Experimental 
CA device
15 5.4±0.5 2.6±0.5 0.06
20 6.8±0.8 6.0±1.7 0.48
25 8.2±1.3 5.8±0.8 0.03
RFA,  radiofrequency ablation; CA,  cryoablation.
＊time until the electric current is automatically shut off when the impedance is rapidly increased
†reference
allowing the passage of a 4-Fr catheter (usually 4.2-Fr in 
diameter).  Third,  the caliber difference between the 
introducer sheath and cryoprobe is minimized because 
of its tapered tip.  Therefore,  the introducer sheath in 
this study was just the right caliber for inserting the 
cryoprobe,  and it easily penetrated the animal liver tis-
sue.  Although the projecting tip length of 2 cm is 
shorter than the expected ice-ball long axis diameter,  
the freezing ability of the cryoprobe may have been 
affected by the introducer sheath.  This problem could 
be solved by withdrawing the sheath outside the ice-ball 
area during the freezing procedure and then pushing it 
through the cryoprobe to the original position.
The term “radiofrequency” applies to coagulation 
induction from all electromagnetic energy sources within 
the radiofrequency spectrum (3 kHz to 300 GHz),  
including “radiofrequency” and “microwave” devices.  
However,  the currently available devices are tradition-
ally designed for RFA in the 375-500 kHz range [16].  
Like the RFA needle in this study,  most devices cur-
rently used are monopolar with a single active electrode.  
On the other hand,  electrosurgical devices are used for 
surgical cutting or to control bleeding by coagulation 
during surgery.  These devices use alternating current at 
different radiofrequency levels.  In a monopolar device,  
heat is produced when electric current encounters resis-
tance from the circuit made by the patient,  electrosur-
gical generator,  active electrode (e.g.,  electrosurgical 
knife),  and return electrode [18 , 19].  In this study,  the 
same circuit was replicated in the laboratory using the 
experimental CA device.  Because the introducer sheath 
provided insulation,  the electric current could only flow 
through the needle tip,  which contacted the liver tissue 
directly without insulation.  This insulation allowed 
only the needle tip to be energized.
Percutaneous CA is a recently developed technique 
for minimally invasive tumor treatment.  Rapid tissue 
freezing and thawing produces cytotoxic effects by dis-
rupting the cellular membranes and inducing cell death 
[17 , 20].  CA has several advantages over other heat-
based thermal ablation techniques; these include excel-
lent visualization of the ablation zone (ice-ball) and 
absence of pain during the procedure.  One of the dis-
advantages of CA is a lack of ability to ablate the needle 
tract.  Wu et al.  reported in their meta-analysis that the 
pooled rate of hemorrhage was 4.14% (18 of 435) in the 
CA group and 1.16% (4 of 346) in the RFA group;  
there was thus a trend toward higher risk of bleeding by 
CA than RFA,  despite a lack of statistical significance 
(OR = 1.92,  95% CI: 0.62-5.88) [8].
Needle tract seeding is a rare but serious complica-
tion of percutaneous thermal ablation treatment 
[10 , 12].  Regarding CA,  an incidence rate of 0.2-0.76% 
has been reported in larger series [11 , 21 , 22].  The pos-
sible mechanisms of tumor seeding are as follows:  
adherence of viable cancer cells to the needle,  blood 
reflux along the tract,  or cancer cells being forced into 
the tract because of increased intratumoral pressure 
[10 , 22].  Cauterization of the needle may be effective in 
the prevention of needle tract seeding [6 , 9 , 12 , 22].
Recently,  a radiofrequency device for tract ablation 
after liver biopsy was reported [24].  Additionally,  a 
newly developed CA device,  with a non-insulated tip 
and insulated basal needle,  has been made available.  
Although needle tract cauterization can be performed 
using this device,  it was actually developed for active 
thawing without helium [25].  Unfortunately,  this device 
is not available in our country; hence,  we cannot con-
firm the effectiveness of needle tract ablation using this 
device.
This experimental model has several limitations.  
First,  the same results might not be obtained with nee-
dle tract ablation of cold liver tissue after CA,  as the 
temperature of the beagle liver in this experiment was 
20°C.  Second,  the caliber difference may present a 
serious problem via the percutaneous approach because 
of puncture resistance.  Ideally,  the CA probe should be 
given a thin insulating coating,  such as an RFA elec-
trode,  although the lack of such coating was not of 
consequence in our experimental study because we 
performed puncture at the laparotomy site,  and liver 
tissue itself is quite soft.  Third,  needle tract ablation 
was performed only in the liver tissue.  Finally,  although 
this device was easily made with commercially available 
products,  this constitutes an off-label use of the cryo-
probe; therefore,  the device cannot be used in humans 
without the permission of the institutional ethics com-
mittee.
In conclusion,  needle tract ablation can be performed 
using our newly developed experimental device com-
bined with an electrosurgical device.  These results will 
have important future implications for reducing the risk 
of bleeding and tumor seeding with CA.
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